1.The first domestic company to independently develop a ChIRP kit.
2.Leading detection methods, accurate results and good repeatability.
3.High sensitivity and low detection limit.
4.High sensitivity and high specificity.
5.Fast detection, easy operation, safe and convenient.
6.BersinbioTM has independent intellectual property rights.
Instructions
Articles
【In 2023】
Periodicals:International Journal of Biological Sciences
IF:9.200
Periodicals:International Journal of Molecular Sciences
IF:5.600
Periodicals:Cancer Cell International
IF:5.800
【In 2022】
Periodicals:Biomarker Research
IF:11.100
Periodicals:Cell Death and Disease
IF:9.000
Periodicals:Molecular Medicine
IF:5.700
【In 2021】
Periodicals:Clinical and Translational Medicine
IF:10.600
Article:Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
Periodicals:Frontiers in Oncology
IF:6.244
【In 2020】
Article:Long Noncoding RNA MRPL23-AS1 Promotes Adenoid Cystic Carcinoma Lung Metastasis
Periodicals:Cancer Research
IF:11.200
Article:Super-Enhancer LncRNA LINC00162 Promotes Progression of Bladder Cancer
Periodicals:iScience
IF:4.447
【In 2019】
Periodicals:Advanced Science
IF:17.521
【In 2017】
Periodicals:Journal of Cellular and Molecular Medicine
IF:4.302
Previous:MeRIP Kit
Next :RNA pulldown Kit